QA: Regenerx Biopharmaceuticals INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000707511_2016_Regenerx_Biopharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000707511, Regenerx Biopharmaceuticals INC

  xvar xval
0 AssetsCurrent 341,927
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,544
3 remainder_Assets 5,752
4 LiabilitiesCurrent 359,041
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 6,741,578
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,452,190
9 ResearchAndDevelopmentExpense 257,125
10 remainder_Expenses 173,477
11 remainder_Revenues 60,612
12 remainder_NetIncome -7,643,699
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 358,223
1 Liabilities 7,100,619
2 Expenses 1,882,792
3 Revenues 60,612
4 StockholdersEquity -6,742,396
5 NetIncome -9,465,879
6 ComprehensiveNetIncome -9,465,879
7 BaseVar 8,522,972
8 EconomicCapitalRatiobeforeLimitedLiability -6.48
9 EconomicCapitalRatio 0.0491

Edgar->Model Mapping

Feature Distribution

Change over Time